BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2286 related articles for article (PubMed ID: 25724480)

  • 1. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
    Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
    Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
    Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis.
    Finck BN
    Diabetes; 2018 Dec; 67(12):2485-2493. PubMed ID: 30459251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
    Byrne CD
    Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
    Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
    World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
    Pettinelli P; Obregón AM; Videla LA
    Nutr Hosp; 2011; 26(3):441-50. PubMed ID: 21892559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome.
    Pacifico L; Giansanti S; Gallozzi A; Chiesa C
    Mini Rev Med Chem; 2014; 14(10):791-804. PubMed ID: 25307311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease as a multi-systemic disease.
    Fotbolcu H; Zorlu E
    World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.
    Miele L; Targher G
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome.
    Wainwright P; Byrne CD
    Int J Mol Sci; 2016 Mar; 17(3):367. PubMed ID: 26978356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease.
    Ziolkowska S; Binienda A; Jabłkowski M; Szemraj J; Czarny P
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
    Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle.
    Alterio A; Alisi A; Liccardo D; Nobili V
    Horm Res Paediatr; 2014; 82(5):283-9. PubMed ID: 25324136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 115.